(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 5. EGL-43 is involved in AC invasion as a downstream target of HLH-2 and
FOS-1. Animals containing cdh-3::CFP (red) were injected with
egl-43 (PR-domain)::YFP constructs. (A-F) The PR-YFP transgene
is expressed (green) in the VU and DU lineages as well as in the AC from early
L2 when using the wild-type egl-43 regulatory region (A,B), and shows
the AC (cdh-3::CFP, white) invasion defect (E). The transgene is
expressed in the VU and DU lineages from late L2, but in the AC from mid-L3,
when using the mutated E-boxes (C,D), and shows normal AC invasion (F).
(G-L) egl-43 RNAi eliminates expression of zmp-1::GFP
(G,H) and him-4::GFP (I,J) in the AC (arrow), but not of
fos-1::YFP (K,L). egl-43 RNAi resulted in two ACs in which
fos-1::YFP is expressed higher than in the neighboring gonadal cells
(L, arrows). (M-R) fos-1 RNAi greatly reduces egl-43
expression in the AC, and in the DU and VU descendants at the L3 molt (M,N)
and at mid-L3 (Q,R), but not at mid-L2 (O,P). Animals from a transgenic line
that expresses egl-43(exon-5)::YFP were used for the fos-1
RNAi.